X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
kidney cancer (3) 3
mutation (3) 3
article (2) 2
carcinoma, renal cell (2) 2
carcinoma, renal cell - genetics (2) 2
carcinoma, renal cell - pathology (2) 2
gene expression regulation, neoplastic (2) 2
humans (2) 2
index medicus (2) 2
kidney neoplasms - genetics (2) 2
kidney neoplasms - pathology (2) 2
physiological aspects (2) 2
tumors (2) 2
adenoma, oxyphilic - classification (1) 1
adenoma, oxyphilic - genetics (1) 1
adenoma, oxyphilic - pathology (1) 1
amino acid sequence (1) 1
angiogenesis (1) 1
animals (1) 1
antagonist drugs (1) 1
arnt (1) 1
aryl hydrocarbon receptor nuclear translocator - genetics (1) 1
aryl hydrocarbon receptor nuclear translocator - metabolism (1) 1
base sequence (1) 1
basic helix-loop-helix transcription factors - antagonists & inhibitors (1) 1
basic helix-loop-helix transcription factors - genetics (1) 1
basic helix-loop-helix transcription factors - metabolism (1) 1
binding sites (1) 1
bioinformatics (1) 1
biomarkers, tumor - genetics (1) 1
cancer therapies (1) 1
carcinoma, renal cell - classification (1) 1
carcinoma, renal cell - drug therapy (1) 1
carcinoma, renal cell - metabolism (1) 1
cell line, tumor (1) 1
cell transformation, neoplastic (1) 1
clinical trials (1) 1
deoxyribonucleic acid--dna (1) 1
dna (1) 1
dna, neoplasm (1) 1
drug resistance, neoplasm - drug effects (1) 1
education (1) 1
epas1 (1) 1
erythropoietin - antagonists & inhibitors (1) 1
erythropoietin - blood (1) 1
expression (1) 1
female (1) 1
gene (1) 1
gene dosage (1) 1
gene expression (1) 1
gene expression profiling (1) 1
gene mutations (1) 1
genes (1) 1
genetic aspects (1) 1
genomes (1) 1
genomic instability (1) 1
health aspects (1) 1
hif-1β (1) 1
hif-2-alpha (1) 1
hif-2α (1) 1
hif2-alpha (1) 1
hypoxia-inducible factor-2 (1) 1
indans - administration & dosage (1) 1
indans - pharmacology (1) 1
indans - therapeutic use (1) 1
indoles - pharmacology (1) 1
indoles - therapeutic use (1) 1
inhibition (1) 1
kidney neoplasms - classification (1) 1
kidney neoplasms - drug therapy (1) 1
kidney neoplasms - metabolism (1) 1
male (1) 1
methods (1) 1
mice (1) 1
mice, inbred nod (1) 1
mice, scid (1) 1
molecular sequence data (1) 1
molecular targeted therapy (1) 1
multidisciplinary sciences (1) 1
neoplasm proteins - genetics (1) 1
neoplasm proteins - physiology (1) 1
oncogene proteins, fusion - genetics (1) 1
oncogene proteins, fusion - physiology (1) 1
pas-b domain (1) 1
patient-derived xenograft (1) 1
polymorphism, single nucleotide (1) 1
protein conformation (1) 1
proteins (1) 1
proto-oncogene proteins c-met - chemistry (1) 1
proto-oncogene proteins c-met - genetics (1) 1
pyrroles - pharmacology (1) 1
pyrroles - therapeutic use (1) 1
rcc (1) 1
renal cancer (1) 1
reproducibility of results (1) 1
research (1) 1
risk factors (1) 1
rna (1) 1
signatures (1) 1
studies (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Genetics, ISSN 1061-4036, 2015, Volume 47, Issue 1, pp. 13 - 21
Journal Article
Nature, ISSN 0028-0836, 2016, Volume 539, Issue 7627, pp. 112 - 117
Clear cell renal cell carcinoma (ccRCC) is characterized by inactivation of the von Hippel-Lindau tumour suppressor gene (VHL)(1,2). Because no other gene is... 
HIF-2-ALPHA | INHIBITION | RNA | GENE | PAS-B DOMAIN | DNA | MULTIDISCIPLINARY SCIENCES | HIF2-ALPHA | HYPOXIA-INDUCIBLE FACTOR-2 | TRANSCRIPTION FACTOR | EXPRESSION | Sulfones - therapeutic use | Kidney Neoplasms - genetics | Humans | Gene Expression Regulation, Neoplastic | Carcinoma, Renal Cell - genetics | Male | Kidney Neoplasms - metabolism | Aryl Hydrocarbon Receptor Nuclear Translocator - metabolism | Molecular Targeted Therapy | Sulfones - pharmacology | Indans - therapeutic use | Erythropoietin - blood | Sunitinib | Basic Helix-Loop-Helix Transcription Factors - metabolism | Female | Indoles - pharmacology | Indans - administration & dosage | Carcinoma, Renal Cell - drug therapy | Pyrroles - therapeutic use | Binding Sites | Reproducibility of Results | Basic Helix-Loop-Helix Transcription Factors - genetics | Carcinoma, Renal Cell - pathology | Basic Helix-Loop-Helix Transcription Factors - antagonists & inhibitors | Mice, SCID | Xenograft Model Antitumor Assays | Carcinoma, Renal Cell - metabolism | Pyrroles - pharmacology | Animals | Cell Transformation, Neoplastic | Cell Line, Tumor | Erythropoietin - antagonists & inhibitors | Indoles - therapeutic use | Kidney Neoplasms - pathology | Mice, Inbred NOD | Aryl Hydrocarbon Receptor Nuclear Translocator - genetics | Mice | Mutation | Kidney Neoplasms - drug therapy | Drug Resistance, Neoplasm - drug effects | Indans - pharmacology | Sulfones - administration & dosage | Physiological aspects | Molecular targeted therapy | Transcription factors | Carcinoma, Renal cell | Methods | kidney cancer | HIF-1β (F446L) | RCC | patient-derived xenograft | EPAS1 | HIF-2α (G323E) | renal cancer | ARNT
Journal Article
Nature, ISSN 0028-0836, 11/2016, Volume 539, Issue 7627, p. 112
Clear cell renal cell carcinoma (ccRCC) is characterized by inactivation of the von Hippel-Lindau tumour suppressor gene (VHL)1,2. Because no other gene is... 
Angiogenesis | Antagonist drugs | Kidney cancer | Clinical trials | Tumorigenesis | Mutation | Gene expression | Vascular endothelial growth factor | Cancer therapies | Tumors
Journal Article
01/2016, ISBN 0355018357
The purpose of this qualitative study was to bring awareness to the issues, challenges, and resources needed to assist grandparent caregivers engaging the... 
Education
Dissertation
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.